# Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control

> **NCT01841008** · PHASE2,PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 35 (actual)

## Conditions studied

- Pigmentation Disorders
- Vitiligo

## Interventions

- **DRUG:** Protopic
- **DRUG:** Placebo : Diprobase

## Key facts

- **NCT ID:** NCT01841008
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2013-06
- **Final completion:** 2014-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01841008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01841008, "Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01841008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*